One of the impacts of the global pandemic has been a vast acceleration in the uptake of innovative technologies to improve the quality, efficiency, and safety in the medical sector. Positive spillovers result in the betterment of patient care, speed in admin within the medical clinics, and the recent adoption of touch-free technologies and systems, contributing to the containment of infection rates.
Here, the cardiovascular disease market, which includes hypertension, dyslipidaemia and thrombotic events, is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022.

Meridian Cardiovascular Systems | raising $4.5M

Part of KapVista’s Ecosystem, Meridian Cardiovascular Systems (MCS) are seeking to raise $4.5M to develop a therapeutic device for the treatment of cardiovascular disease, making stents unnecessary and reducing the need for bypass surgery, as well as limb amputations by providing a disposable catheter device to remove plaque from arteries.

As the number of patients in the USA who suffer from Coronary (CAD) and Peripheral Artery Disease (PAD) due to plaque deposits in their arteries exceeds 24 million. Current treatments have less than desirable clinical outcomes. The use of stents damages arterial walls, bypass surgery is very traumatic and costly, while limb amputations to treat PAD are a devastating option.

MCS’ device employs modified directional radiofrequency (RF) energy. It gently disrupts, debulks, and vaporizes plaque. The catheter also incorporates real-time 3D ultrasound that provides guidance to the cardiologist during the procedure.

If you’d like us to make an introduction to the founding team or access their pitch deck, get in touch with us to Register interest.